Menopause Supplements Market Top Players, Segments & Regional Trends By 2034
Straits Research released its highly anticipated report, “Global Menopause Supplements Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 18.66 billion in 2025 and is projected to expand to USD 30.20 billion by 2034, registering a compound annual growth rate (CAGR) of 5.54%.
Market Dynamics
The global menopause supplements market is experiencing steady growth, driven primarily by the increasing awareness among women regarding menopause related health issues and the rising demand for natural and safe alternatives to hormone replacement therapy. As more women seek to manage symptoms such as hot flashes, mood swings, sleep disturbances, and bone health concerns, dietary supplements containing phytoestrogens, vitamins, minerals, and herbal extracts are gaining popularity. This trend is further supported by the expansion of health and wellness channels, including online retail platforms, which are improving accessibility and convenience for consumers worldwide. Additionally, growing emphasis on preventive healthcare and healthy aging is encouraging women to adopt supplements that support overall well-being during the menopausal transition.
However, the market faces challenges due to regulatory constraints and inconsistent clinical evidence supporting the efficacy of certain menopause supplements. Variations in regulatory standards across regions, coupled with limited awareness regarding dosage, restrict market adoption in developing economies.
On the other hand, significant opportunities exist for market players through product innovation and the development of targeted formulations that address specific symptoms or comorbidities associated with menopause. Emerging markets, where the female population is increasingly health-conscious and seeking natural therapeutic options, offer substantial growth potential. Companies that invest in educational campaigns, clinical validation, and region-specific marketing strategies are positioned to capture this expanding consumer base and strengthen their presence in the global menopause supplements market.
Market Highlights
-
Type: The non-hormonal supplements segment dominated the market in 2025.
Dosage Form: The tablet & capsule segment dominated the market with a revenue share of 32.78% in 2025.
Distribution Channel: The drug stores & retail pharmacies segment dominated the market with a revenue share of 37.61% in 2025.
Regional Insights: North America dominated the global market, accounting for 39.62% share in 2025. This growth is attributed to the widespread acceptance of dietary supplements.
Amway APD Pharmaceutical Manufacturing Pte Ltd Bayer AG Blackmores GNC Holdings, Inc. Herbalife Nutrition Ltd. Korra Lab Metagenics, Inc. MyPause Health pty ltd Nature's Way Products LLC OZ Health Singapore Pfizer Inc. Pharmavite Prelude Health Pure Encapsulations, LLC RED SUN Solgar Inc. Thorne William Reed Ltd Others Recent Developments
October 2025: Hims & Hers Health, Inc. launched a new specialty in women's health, offering access to affordable treatment plans built specifically for women experiencing perimenopause and menopause.
SegmentationBy Type (2026-2034) Hormonal Supplements Non-hormonal Supplements Herbal Supplements Vitamins And Minerals Others By Dosage Form (2026-2034) Tablet & Capsule Powder Liquid Others By Distribution Channel (2026-2034) Drug Stores & Retail Pharmacies Hospital Pharmacies Online Stores Others
Want to see full report on
Menopause Supplements Market Full Report
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment